SCHEMBL2373770

SCHEMBL2373770

CCCCCCCC(CCC)(CCCCCC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
MEN1 O00255 1/20 0.44
ESR1 P03372 1/20 0.44
ALOX15 P16050 1/20 0.44
PDE4A P27815 1/20 0.44
KMT2A Q03164 1/20 0.44
PDE3A Q14432 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2345868 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL29014394 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL28371056 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL7770813 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL4587476 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL2139412 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL2138537 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL3632979 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL2141446 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA
SCHEMBL27775545 1.00 CES2 (0.45) CES2GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319884-B1 COSMETIC COMPOSITION COMPRISING HINOKITIOL UNILEVER IP HOLDINGS B V (NL) 2026-05-27 EP claimed
EP-3833447-B1 ANHYDROUS COSMETIC COMPOSITION COMPRISING VEGETABLE OIL CLARINS LAB (FR) 2025-02-26 EP claimed
EP-3923900-B1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE BEIERSDORF AG (DE) 2023-12-27 EP claimed
EP-3714865-B1 COSMETIC COMPOSITION WITH HIGH CONTENT OF TRIAZINE DERIVATIVE SOLAR FILTERS THOREL JEAN NOEL (FR) 2023-08-02 EP claimed
EP-3419588-B1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC (US) 2023-04-05 EP claimed
EP-4025178-B1 NOVEL SYSTEM FOR SOLUBILISING FAT-SOLUBLE ORGANIC SUN FILTERS FABRE PIERRE DERMO COSMETIQUE (FR) 2023-01-18 EP claimed
EP-3923900-A1 ODOR-STABLE ETHANOLIC PREPARATION CONTAINING OCTOCRYLENE Beiersdorf AG (DE) 2021-12-22 EP claimed
CN-109379887-B Topical compositions based on carnosine-magnesium complexes 完胜股份有限公司 2021-12-21 CN claimed
US-10973868-B2 Composition for topical use based on a carnosine-magnesium complex OUTPLAY, INC. 2021-04-13 US claimed
EP-3258942-B1 COSMETIC AND TOPICAL COMPOSITIONS COMPRISING CANNABIGEROL AND CANNABIDIOL APIRX PHARMACEUTICAL USA LLC (US) 2021-01-13 EP claimed
EP-3437626-A1 SUNSCREEN WITH LOW EYE IRRITATION POTENTIAL Beiersdorf AG (DE) 2019-02-06 EP claimed
EP-3419588-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX Outplay Inc. (CA) 2019-01-02 EP claimed
EP-2750680-B1 COMPOSITION FOR TREATING LICE INFESTATION LEVIN ORNA (IL) 2018-12-26 EP claimed
EP-3056192-B1 Complete anhydrous sunscreen composition with under water technology FREZYDERM S A (GR) 2018-11-21 EP claimed
EP-2934462-B1 TWO-PHASE DEVELOPER FOR OXIDATIVE COLOR CHANGING AGENTS HENKEL AG & CO KGAA (DE) 2017-11-29 EP claimed
WO-2017145030-A1 COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC. (CA) 2017-08-31 WO claimed
WO-2017144937-A1 COMPOSITIONS FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX OUTPLAY INC. (CA) 2017-08-31 WO claimed
EP-2783690-B1 NEW USE OF NEOHESPERIDIN NATURAL MEDICINE INST ZHEJIANG YANGSHENGTANG CO LTD (CN) 2017-04-26 EP claimed
EP-2596787-B1 NEW USE OF HESPERETIN NATURAL MEDICINE INST ZHEJIANG YANGSHENGTANG CO LTD (CN) 2015-11-25 EP claimed
EP-2456445-B1 AGENT FOR THE TREATMENT OF SKIN CONDITIONS POHL BOSKAMP G GMBH & CO KG (DE) 2014-05-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10973868-B2 Composition for topical use based on a carnosine-magnesium complex CKMT1A; CKMT1B, S100A6, S100A4 CES2 1090/4885GPR84 1025/4885PPARG 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.